FEBUXOSTAT TABLETS 40 MG

FEBUXOSTAT TABLETS 40 MG was reported 10430 times

FEBUXOSTAT TABLETS 40 MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RED BLOOD CELL SEDIMENTATION RATE 116 0.4158
1 CONGENITAL DIAPHRAGMATIC ANOMALY 10 0.2778
2 CYTOMEGALOVIRUS NEPHRITIS 11 0.2075
3 HYPERKINETIC HEART SYNDROME 9 0.1525
4 GRANULOMA SKIN 125 0.1523
5 SPLENIC NECROSIS 13 0.1512
6 ADENOVIRUS INTERSTITIAL NEPHRITIS 7 0.1250
7 POLYCYSTIC LIVER DISEASE 13 0.1226
8 ENTHESOPATHY 187 0.1195
9 BLOOD PARATHYROID HORMONE DECREASED 144 0.0971
10 POST INFECTION GLOMERULONEPHRITIS 7 0.0833
11 OSTEOMA 13 0.0722
12 TENOSYNOVITIS 188 0.0681
13 GLUCOSE URINE 10 0.0667
14 HAEMOGLOBIN URINE PRESENT 13 0.0640
15 ALANINE AMINOTRANSFERASE ABNORMAL 133 0.0630
16 SPLENIC CYST 13 0.0622
17 PANNICULITIS 144 0.0595
18 RESPIRATORY TRACT HAEMORRHAGE 33 0.0553
19 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 13 0.0526
20 RHEUMATOID NODULE 143 0.0519
21 METASTASES TO SOFT TISSUE 13 0.0502
22 RHEUMATOID LUNG 45 0.0471
23 DRUG CROSS-REACTIVITY 7 0.0391
24 CEREBRAL VENTRICULAR RUPTURE 7 0.0383
25 SPLENIC LESION 14 0.0378
26 IMMOBILISATION SYNDROME 8 0.0376
27 LORDOSIS 13 0.0370
28 C-REACTIVE PROTEIN ABNORMAL 183 0.0285
29 SKIN NECROSIS 148 0.0285
30 BLOOD BETA-D-GLUCAN INCREASED 8 0.0261
31 TONGUE DISORDER 187 0.0258
32 DRUG TOLERANCE DECREASED 70 0.0249
33 LOW CARDIAC OUTPUT SYNDROME 8 0.0240
34 PSEUDOPORPHYRIA 8 0.0234
35 BETA 2 MICROGLOBULIN INCREASED 6 0.0230
36 BLOOD URIC ACID DECREASED 11 0.0226
37 PNEUMONIA HAEMOPHILUS 10 0.0206
38 URINARY SEDIMENT PRESENT 13 0.0202
39 GOUTY ARTHRITIS 16 0.0201
40 CEREBRAL ARTERY THROMBOSIS 10 0.0195
41 HYPERURICAEMIA 80 0.0194
42 PROTHROMBIN TIME ABNORMAL 13 0.0188
43 THROMBOTIC CEREBRAL INFARCTION 7 0.0186
44 THALAMUS HAEMORRHAGE 16 0.0184
45 ORTHOSTATIC INTOLERANCE 13 0.0181
46 GRANULOMA 60 0.0173
47 SYSTEMIC INFECTION 27 0.0163
48 RED BLOOD CELLS URINE POSITIVE 15 0.0155
49 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 10 0.0152
50 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 10 0.0151
51 CARDIAC FAILURE CHRONIC 64 0.0150
52 TUMOUR LYSIS SYNDROME 129 0.0146
53 RENAL ISCHAEMIA 8 0.0146
54 RED BLOOD CELL ABNORMALITY 14 0.0146
55 HYPERCALCAEMIA 176 0.0142
56 HYPERCREATININAEMIA 7 0.0139
57 ENANTHEMA 8 0.0139
58 SUPERINFECTION BACTERIAL 11 0.0139
59 HYPOPARATHYROIDISM 10 0.0130
60 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 13 0.0125
61 TENDONITIS 190 0.0123
62 HYPERMAGNESAEMIA 8 0.0123
63 FOLATE DEFICIENCY 14 0.0121
64 CORONAVIRUS TEST POSITIVE 12 0.0117
65 PRERENAL FAILURE 16 0.0113
66 OSTEOCHONDROSIS 13 0.0112
67 SYPHILIS 8 0.0110
68 FEAR OF INJECTION 78 0.0109
69 DRUG ERUPTION 190 0.0107
70 FULMINANT TYPE 1 DIABETES MELLITUS 11 0.0107
71 DRUG TOLERANCE 54 0.0107
72 PERIODONTITIS 23 0.0106
73 HAEMATOCRIT ABNORMAL 13 0.0106
74 RED BLOOD CELL SEDIMENTATION RATE INCREASED 116 0.0105
75 BLOOD URIC ACID INCREASED 60 0.0104
76 HEAT ILLNESS 7 0.0104
77 BLOOD BILIRUBIN ABNORMAL 13 0.0101
78 SYNOVITIS 182 0.0101
79 UPPER RESPIRATORY TRACT INFLAMMATION 12 0.0100
80 CARDIAC AMYLOIDOSIS 11 0.0100
81 CARDIAC FAILURE ACUTE 65 0.0097
82 PHYSICAL DECONDITIONING 25 0.0097
83 DIFFERENTIATION SYNDROME 7 0.0095
84 URETEROLITHIASIS 10 0.0095
85 ULCER 149 0.0094
86 BASAL CELL CARCINOMA 146 0.0093
87 HYPERPHOSPHATAEMIA 20 0.0093
88 MULTIPLE DRUG THERAPY 7 0.0093
89 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 8 0.0091
90 CYTOMEGALOVIRUS ENTEROCOLITIS 7 0.0091
91 BRAIN NATRIURETIC PEPTIDE INCREASED 28 0.0091
92 SMALL INTESTINAL PERFORATION 17 0.0091
93 LABORATORY TEST INTERFERENCE 7 0.0089
94 EROSIVE DUODENITIS 7 0.0088
95 LUNG OPACITY 23 0.0087
96 MEAN CELL HAEMOGLOBIN INCREASED 14 0.0084
97 CEREBELLAR INFARCTION 14 0.0083
98 RENAL ATROPHY 10 0.0080
99 WHITE BLOOD CELLS URINE POSITIVE 15 0.0080
100 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 11 0.0078
101 NEPHROGENIC ANAEMIA 36 0.0078
102 PROTEIN URINE 7 0.0077
103 DIABETIC NEPHROPATHY 17 0.0077
104 IMMUNE-MEDIATED HEPATIC DISORDER 15 0.0077
105 HAEMATOMA MUSCLE 9 0.0075
106 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 7 0.0074
107 CYTOMEGALOVIRUS TEST POSITIVE 13 0.0073
108 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 8 0.0071
109 AORTIC ARTERIOSCLEROSIS 18 0.0070
110 GOUT 125 0.0070
111 HYPOPROTEINAEMIA 13 0.0068
112 OSTEOLYSIS 14 0.0068
113 PROCALCITONIN INCREASED 8 0.0068
114 NON-ALCOHOLIC STEATOHEPATITIS 7 0.0068
115 BLAST CELL COUNT INCREASED 7 0.0067
116 DIVERTICULUM INTESTINAL HAEMORRHAGIC 15 0.0067
117 SKIN ULCER 172 0.0066
118 BILE DUCT STONE 21 0.0066
119 C-REACTIVE PROTEIN INCREASED 239 0.0066
120 CONTRAINDICATED PRODUCT ADMINISTERED 197 0.0065
121 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 16 0.0065
122 HYPOPITUITARISM 11 0.0063
123 HYPERKALAEMIA 221 0.0063
124 POST HERPETIC NEURALGIA 9 0.0063
125 CYTOKINE RELEASE SYNDROME 125 0.0062
126 NORMOCYTIC ANAEMIA 9 0.0061
127 LINEAR IGA DISEASE 10 0.0060
128 MARASMUS 9 0.0059
129 HAEMORRHAGE SUBCUTANEOUS 21 0.0059
130 HYPOALBUMINAEMIA 46 0.0059
131 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 9 0.0059
132 DERMATITIS EXFOLIATIVE GENERALISED 20 0.0057
133 CEREBRAL ARTERY EMBOLISM 7 0.0057
134 CHRONIC FATIGUE SYNDROME 8 0.0057
135 ECHOCARDIOGRAM ABNORMAL 8 0.0057
136 BRASH SYNDROME 8 0.0057
137 EMBOLIC STROKE 20 0.0057
138 PNEUMONIA BACTERIAL 52 0.0057
139 INTRA-ABDOMINAL HAEMATOMA 7 0.0056
140 AORTIC VALVE STENOSIS 10 0.0056
141 VENTRICULAR HYPOKINESIA 18 0.0056
142 SKIN EROSION 18 0.0056
143 RENAL IMPAIRMENT 469 0.0056
144 ASPARTATE AMINOTRANSFERASE INCREASED 293 0.0055
145 IMMUNE-MEDIATED LUNG DISEASE 10 0.0055
146 IGA NEPHROPATHY 9 0.0054
147 BENIGN PROSTATIC HYPERPLASIA 28 0.0054
148 IMMUNE-MEDIATED HEPATITIS 11 0.0054
149 MIXED LIVER INJURY 16 0.0053
150 DYSLIPIDAEMIA 27 0.0053
151 HEPATIC CYST 18 0.0053
152 PEMPHIGOID 40 0.0053
153 HEPATIC MASS 10 0.0052
154 CONCOMITANT DISEASE AGGRAVATED 32 0.0052
155 HAEMOTHORAX 15 0.0052
156 CHOLANGITIS 32 0.0052
157 ANAEMIA MACROCYTIC 11 0.0051
158 PNEUMONIA CYTOMEGALOVIRAL 10 0.0051
159 ACUTE MYELOID LEUKAEMIA RECURRENT 11 0.0051
160 BLOOD PRESSURE SYSTOLIC INCREASED 99 0.0051
161 MEAN CELL VOLUME INCREASED 13 0.0051
162 FIBRIN D DIMER INCREASED 18 0.0051
163 IMMUNE-MEDIATED MYOCARDITIS 8 0.0050
164 CARDIAC FAILURE 395 0.0049
165 CALCIPHYLAXIS 9 0.0049
166 DISSEMINATED INTRAVASCULAR COAGULATION 69 0.0049
167 CEREBELLAR HAEMORRHAGE 7 0.0049
168 PSORIATIC ARTHROPATHY 196 0.0048
169 QUADRIPARESIS 8 0.0048
170 CYTOMEGALOVIRUS COLITIS 11 0.0048
171 BLOOD PHOSPHORUS INCREASED 13 0.0048
172 RIGHT VENTRICULAR FAILURE 33 0.0047
173 ENTERITIS INFECTIOUS 8 0.0047
174 IMMUNE-MEDIATED ENTEROCOLITIS 17 0.0046
175 LACUNAR INFARCTION 11 0.0046
176 PSEUDOMONAL SEPSIS 8 0.0046
177 GASTROINTESTINAL OEDEMA 8 0.0045
178 NEOPLASM SKIN 7 0.0045
179 ALANINE AMINOTRANSFERASE INCREASED 276 0.0045
180 BLOOD CREATININE INCREASED 293 0.0045
181 PNEUMOCYSTIS JIROVECII PNEUMONIA 45 0.0045
182 HEPATIC FUNCTION ABNORMAL 167 0.0045
183 SMALL INTESTINAL HAEMORRHAGE 9 0.0045
184 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 39 0.0044
185 VENOUS THROMBOSIS LIMB 9 0.0044
186 INTERNATIONAL NORMALISED RATIO ABNORMAL 15 0.0044
187 PNEUMONIA KLEBSIELLA 8 0.0043
188 TOXIC EPIDERMAL NECROLYSIS 66 0.0043
189 VARICELLA ZOSTER VIRUS INFECTION 9 0.0043
190 ENTEROCOLITIS 25 0.0043
191 GLOMERULAR FILTRATION RATE DECREASED 53 0.0043
192 CARDIAC DYSFUNCTION 16 0.0043
193 ATRIAL TACHYCARDIA 9 0.0043
194 CYTOMEGALOVIRUS VIRAEMIA 19 0.0043
195 NEUTROPHIL COUNT DECREASED 174 0.0043
196 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 10 0.0043
197 INTESTINAL POLYP 7 0.0043
198 GENERALISED ERYTHEMA 24 0.0042
199 ACUTE KIDNEY INJURY 636 0.0042
200 ABDOMINAL WALL HAEMATOMA 8 0.0041
201 PULMONARY ALVEOLAR HAEMORRHAGE 23 0.0041
202 BLADDER NEOPLASM 7 0.0041
203 PYELONEPHRITIS ACUTE 8 0.0041
204 PNEUMONIA FUNGAL 16 0.0041
205 CHOLESTATIC LIVER INJURY 9 0.0040
206 CHOLANGIOCARCINOMA 6 0.0040
207 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 193 0.0040
208 CEREBRAL INFARCTION 98 0.0040
209 AZOTAEMIA 16 0.0040
210 OSTEOMYELITIS 72 0.0040
211 DISTRIBUTIVE SHOCK 9 0.0040
212 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 7 0.0040
213 IMMUNE THROMBOCYTOPENIA 18 0.0039
214 JOINT INJURY 83 0.0039
215 PNEUMOMEDIASTINUM 7 0.0039
216 AKINESIA 8 0.0039
217 TUMOUR HAEMORRHAGE 11 0.0039
218 DUODENAL ULCER HAEMORRHAGE 11 0.0038
219 PROCEDURAL HAEMORRHAGE 15 0.0038
220 FAECALOMA 21 0.0038
221 SINUS NODE DYSFUNCTION 7 0.0038
222 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 10 0.0038
223 AMYLASE INCREASED 14 0.0038
224 ACUTE MYELOID LEUKAEMIA 59 0.0038
225 LEFT VENTRICULAR FAILURE 13 0.0038
226 HYPERKINESIA 8 0.0038
227 ORTHOPNOEA 12 0.0038
228 ESCHERICHIA URINARY TRACT INFECTION 16 0.0038
229 BLOOD UREA INCREASED 63 0.0038
230 INTERSTITIAL LUNG DISEASE 182 0.0038
231 PAINFUL RESPIRATION 9 0.0037
232 CARDIOVASCULAR INSUFFICIENCY 6 0.0037
233 LYMPHOCYTE COUNT DECREASED 65 0.0037
234 GASTRIC PERFORATION 10 0.0037
235 THYROIDITIS 11 0.0037
236 HENOCH-SCHONLEIN PURPURA 8 0.0037
237 MYELOFIBROSIS 11 0.0036
238 INTRAVENTRICULAR HAEMORRHAGE 9 0.0036
239 CONCOMITANT DISEASE PROGRESSION 7 0.0036
240 POTENTIATING DRUG INTERACTION 12 0.0036
241 MUSCULOSKELETAL DISORDER 68 0.0036
242 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 21 0.0035
243 CHRONIC GASTRITIS 8 0.0035
244 ERYTHEMA MULTIFORME 33 0.0035
245 COMPLICATIONS OF TRANSPLANTED KIDNEY 8 0.0035
246 HYPOCALCAEMIA 66 0.0035
247 TUBULOINTERSTITIAL NEPHRITIS 65 0.0035
248 ADRENAL INSUFFICIENCY 42 0.0035
249 INFUSION RELATED REACTION 229 0.0035
250 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 14 0.0034
251 HAEMOGLOBIN ABNORMAL 22 0.0034
252 FEBRILE NEUTROPENIA 226 0.0034
253 HEPATITIS ACUTE 22 0.0034
254 LOWER GASTROINTESTINAL HAEMORRHAGE 25 0.0034
255 BACTERAEMIA 40 0.0034
256 ILEUS PARALYTIC 15 0.0034
257 IRON DEFICIENCY ANAEMIA 31 0.0034
258 BLOOD LACTATE DEHYDROGENASE INCREASED 53 0.0033
259 NON-SMALL CELL LUNG CANCER 16 0.0033
260 RASH PRURITIC 181 0.0033
261 HYPERCAPNIA 10 0.0033
262 MELAENA 73 0.0033
263 INFLAMMATION 171 0.0033
264 KERATITIS 10 0.0033
265 HAEMORRHOIDAL HAEMORRHAGE 16 0.0033
266 CONDUCTION DISORDER 6 0.0033
267 IMMUNE-MEDIATED MYOSITIS 9 0.0033
268 RENAL TUBULAR NECROSIS 32 0.0033
269 SUPRAVENTRICULAR EXTRASYSTOLES 11 0.0033
270 ANURIA 28 0.0033
271 PULMONARY TOXICITY 23 0.0032
272 GASTRIC ULCER HAEMORRHAGE 18 0.0032
273 STAPHYLOCOCCAL SEPSIS 16 0.0032
274 HEPATIC LESION 14 0.0032
275 GASTRITIS EROSIVE 15 0.0032
276 PROTEIN URINE PRESENT 16 0.0032
277 ADENOCARCINOMA OF COLON 6 0.0032
278 APLASIA PURE RED CELL 11 0.0032
279 PLATELET COUNT ABNORMAL 19 0.0031
280 HYPOKALAEMIA 144 0.0031
281 PNEUMONIA ASPIRATION 77 0.0031
282 SHOCK HAEMORRHAGIC 25 0.0031
283 CYTOMEGALOVIRUS INFECTION 51 0.0031
284 APLASIA 6 0.0031
285 NEPHROTIC SYNDROME 21 0.0031
286 HEPATOCELLULAR CARCINOMA 23 0.0030
287 RENAL FUNCTION TEST ABNORMAL 14 0.0030
288 ALTERED STATE OF CONSCIOUSNESS 65 0.0030
289 CHOLECYSTITIS ACUTE 17 0.0030
290 LUNG ADENOCARCINOMA 9 0.0030
291 CYTOMEGALOVIRUS INFECTION REACTIVATION 13 0.0029
292 HYPOVOLAEMIC SHOCK 14 0.0029
293 ATRIAL THROMBOSIS 6 0.0029
294 OLIGURIA 18 0.0029
295 BRONCHITIS CHRONIC 7 0.0029
296 EOSINOPHILIC PNEUMONIA 9 0.0029
297 HAEMOGLOBIN INCREASED 13 0.0028
298 HEPATITIS B REACTIVATION 9 0.0028
299 ORGANISING PNEUMONIA 14 0.0028
300 MULTIPLE ORGAN DYSFUNCTION SYNDROME 80 0.0028
301 HYPOMAGNESAEMIA 39 0.0028
302 STEVENS-JOHNSON SYNDROME 62 0.0028
303 CORONARY ARTERY STENOSIS 14 0.0028
304 RHABDOMYOLYSIS 116 0.0028
305 TOXIC SKIN ERUPTION 28 0.0028
306 DERMATITIS BULLOUS 20 0.0028
307 PULMONARY FIBROSIS 53 0.0028
308 PULMONARY ARTERIAL HYPERTENSION 40 0.0028
309 STRESS CARDIOMYOPATHY 16 0.0027
310 MUSCLE HAEMORRHAGE 11 0.0027
311 CARDIAC TAMPONADE 13 0.0027
312 FEMORAL NECK FRACTURE 14 0.0027
313 CYSTITIS HAEMORRHAGIC 11 0.0027
314 DIFFUSE LARGE B-CELL LYMPHOMA 21 0.0027
315 CORONAVIRUS INFECTION 18 0.0027
316 LACTIC ACIDOSIS 88 0.0027
317 DRUG-INDUCED LIVER INJURY 85 0.0027
318 THERAPY NON-RESPONDER 121 0.0027
319 ANAEMIA 511 0.0027
320 MYELOSUPPRESSION 96 0.0027
321 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 20 0.0027
322 ATRIAL FLUTTER 21 0.0026
323 MYELODYSPLASTIC SYNDROME 38 0.0026
324 HYPERNATRAEMIA 13 0.0026
325 THROMBOTIC MICROANGIOPATHY 25 0.0026
326 PLEURAL EFFUSION 156 0.0026
327 GENERAL PHYSICAL HEALTH DETERIORATION 296 0.0026
328 SUBDURAL HAEMORRHAGE 7 0.0026
329 DUODENAL ULCER 18 0.0025
330 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 65 0.0025
331 PLATELET COUNT DECREASED 268 0.0025
332 PULMONARY CONGESTION 33 0.0025
333 BACTERIAL SEPSIS 8 0.0025
334 COVID-19 PNEUMONIA 29 0.0025
335 SUBARACHNOID HAEMORRHAGE 25 0.0025
336 LYMPHOCYTE COUNT INCREASED 8 0.0024
337 VENTRICULAR TACHYCARDIA 40 0.0024
338 DISEASE COMPLICATION 11 0.0024
339 HIGH DENSITY LIPOPROTEIN DECREASED 8 0.0024
340 HYPERTRIGLYCERIDAEMIA 14 0.0024
341 SPINAL OSTEOARTHRITIS 21 0.0024
342 BUNDLE BRANCH BLOCK LEFT 10 0.0024
343 PANCREATITIS ACUTE 53 0.0024
344 FEBRILE BONE MARROW APLASIA 10 0.0024
345 ASCITES 69 0.0023
346 HAEMOLYTIC ANAEMIA 21 0.0023
347 TYPE 1 DIABETES MELLITUS 14 0.0023
348 CHRONIC LYMPHOCYTIC LEUKAEMIA 11 0.0023
349 PROTEINURIA 44 0.0023
350 LARGE INTESTINE POLYP 16 0.0023
351 DRUG INTOLERANCE 222 0.0023
352 TORSADE DE POINTES 18 0.0023
353 ACUTE CORONARY SYNDROME 19 0.0023
354 KIDNEY TRANSPLANT REJECTION 11 0.0023
355 CAROTID ARTERY STENOSIS 8 0.0023
356 URINE OUTPUT DECREASED 20 0.0023
357 CHEST X-RAY ABNORMAL 7 0.0023
358 BLOOD POTASSIUM ABNORMAL 6 0.0022
359 POLYMYALGIA RHEUMATICA 7 0.0022
360 ENTERITIS 14 0.0022
361 FOOD INTOLERANCE 8 0.0022
362 AORTIC DISSECTION 9 0.0022
363 PROTHROMBIN TIME PROLONGED 13 0.0022
364 PULMONARY HAEMORRHAGE 17 0.0022
365 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 11 0.0022
366 EOSINOPHILIA 38 0.0022
367 HEPATITIS B 13 0.0022
368 ANGINA UNSTABLE 14 0.0022
369 EYELID OEDEMA 25 0.0021
370 HYDRONEPHROSIS 16 0.0021
371 CHRONIC KIDNEY DISEASE 162 0.0021
372 ANTIPSYCHOTIC DRUG LEVEL INCREASED 6 0.0021
373 BLOOD CREATINE PHOSPHOKINASE INCREASED 61 0.0021
374 SCOLIOSIS 13 0.0021
375 CHOLECYSTITIS 25 0.0021
376 ACIDOSIS 16 0.0021
377 HYPERLIPIDAEMIA 25 0.0021
378 UPPER GASTROINTESTINAL HAEMORRHAGE 35 0.0021
379 PYELONEPHRITIS 18 0.0021
380 ATRIOVENTRICULAR BLOCK FIRST DEGREE 9 0.0021
381 SEPTIC SHOCK 90 0.0021
382 CEREBRAL HAEMORRHAGE 74 0.0021
383 PANCYTOPENIA 115 0.0021
384 SPINAL COMPRESSION FRACTURE 17 0.0021
385 ELECTROCARDIOGRAM ABNORMAL 16 0.0020
386 METABOLIC ACIDOSIS 65 0.0020
387 HYPOPHOSPHATAEMIA 15 0.0020
388 HAEMATOCHEZIA 112 0.0020
389 RHINITIS ALLERGIC 9 0.0020
390 TRICUSPID VALVE INCOMPETENCE 16 0.0020
391 BLOOD CULTURE POSITIVE 6 0.0020
392 LIVER DISORDER 88 0.0020
393 TOXIC ENCEPHALOPATHY 10 0.0020
394 CONJUNCTIVAL HYPERAEMIA 7 0.0020
395 DEVICE RELATED INFECTION 30 0.0019
396 PALLOR 53 0.0019
397 ATRIOVENTRICULAR BLOCK COMPLETE 13 0.0019
398 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
399 ATRIOVENTRICULAR BLOCK 15 0.0019
400 GAMMA-GLUTAMYLTRANSFERASE INCREASED 43 0.0019
401 LOW DENSITY LIPOPROTEIN INCREASED 15 0.0019
402 AGRANULOCYTOSIS 36 0.0019
403 DRUG LEVEL INCREASED 32 0.0019
404 ACUTE MYOCARDIAL INFARCTION 57 0.0019
405 FLANK PAIN 18 0.0019
406 BLOOD BLISTER 6 0.0019
407 THERAPEUTIC PRODUCT EFFECT DECREASED 86 0.0019
408 CUTANEOUS VASCULITIS 7 0.0019
409 HYPOTHYROIDISM 61 0.0019
410 PRESCRIBED UNDERDOSE 38 0.0019
411 SERUM FERRITIN INCREASED 10 0.0019
412 AORTIC VALVE INCOMPETENCE 8 0.0019
413 SPLENOMEGALY 22 0.0019
414 TREATMENT FAILURE 155 0.0019
415 LEFT VENTRICULAR HYPERTROPHY 8 0.0019
416 HUMERUS FRACTURE 9 0.0019
417 MYASTHENIA GRAVIS 15 0.0019
418 MITRAL VALVE INCOMPETENCE 21 0.0019
419 PLEURISY 11 0.0019
420 OEDEMA PERIPHERAL 225 0.0018
421 TACHYPNOEA 25 0.0018
422 TONGUE OEDEMA 7 0.0018
423 LIPASE INCREASED 14 0.0018
424 HAEMATOCRIT DECREASED 36 0.0018
425 ELECTROLYTE IMBALANCE 21 0.0018
426 HYPERAMMONAEMIA 9 0.0018
427 ATRIAL FIBRILLATION 175 0.0018
428 HAEMOPTYSIS 50 0.0018
429 BLOOD POTASSIUM INCREASED 29 0.0018
430 CEREBRAL HAEMATOMA 6 0.0018
431 ANGINA PECTORIS 51 0.0018
432 COLITIS ISCHAEMIC 12 0.0018
433 ILEUS 22 0.0018
434 UVEITIS 24 0.0018
435 LYMPHOPENIA 25 0.0018
436 URINE ABNORMALITY 8 0.0018
437 OESOPHAGEAL CANDIDIASIS 7 0.0018
438 AUTOIMMUNE HAEMOLYTIC ANAEMIA 6 0.0017
439 PSEUDOMONAS INFECTION 15 0.0017
440 LUMBAR VERTEBRAL FRACTURE 8 0.0017
441 COLON CANCER 26 0.0017
442 MYOPATHY 15 0.0017
443 BLOOD CREATININE ABNORMAL 6 0.0017
444 BRADYCARDIA 92 0.0017
445 GASTRIC DISORDER 59 0.0017
446 ROSACEA 8 0.0017
447 HYPERTENSIVE CRISIS 19 0.0017
448 WHITE BLOOD CELL COUNT DECREASED 184 0.0017
449 GLUCOSE TOLERANCE IMPAIRED 10 0.0017
450 PRODUCT PRESCRIBING ERROR 40 0.0017
451 BRONCHOPULMONARY ASPERGILLOSIS 13 0.0017
452 HYPOGAMMAGLOBULINAEMIA 11 0.0017
453 HAEMATURIA 57 0.0017
454 FAECES SOFT 12 0.0016
455 GASTROENTERITIS 24 0.0016
456 PERICARDIAL EFFUSION 38 0.0016
457 PULMONARY TUBERCULOSIS 7 0.0016
458 ARTHROPATHY 91 0.0016
459 HYPERGLYCAEMIA 59 0.0016
460 HYPERVOLAEMIA 8 0.0016
461 HEPATIC ENCEPHALOPATHY 15 0.0016
462 SUBDURAL HAEMATOMA 23 0.0016
463 DIVERTICULUM INTESTINAL 7 0.0016
464 DERMATITIS EXFOLIATIVE 8 0.0016
465 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 113 0.0016
466 CIRCULATORY COLLAPSE 27 0.0016
467 PULMONARY HYPERTENSION 33 0.0016
468 HICCUPS 13 0.0016
469 DECREASED APPETITE 365 0.0016
470 OEDEMA 85 0.0016
471 HYPONATRAEMIA 88 0.0016
472 MYOSITIS 14 0.0016
473 EOSINOPHIL COUNT INCREASED 13 0.0016
474 IRON DEFICIENCY 7 0.0016
475 ORTHOSTATIC HYPOTENSION 27 0.0015
476 DIZZINESS POSTURAL 15 0.0015
477 DYSPNOEA EXERTIONAL 58 0.0015
478 GENERALISED OEDEMA 19 0.0015
479 APLASTIC ANAEMIA 8 0.0015
480 CELLULITIS 77 0.0015
481 ARRHYTHMIA 72 0.0015
482 BLOOD PRESSURE DECREASED 101 0.0015
483 HAEMATOMA 39 0.0015
484 ABDOMINAL PAIN LOWER 38 0.0015
485 NEPHROPATHY 14 0.0015
486 EPISTAXIS 112 0.0015
487 COMPRESSION FRACTURE 8 0.0015
488 DRUG INTERACTION 236 0.0015
489 ANAL ABSCESS 8 0.0015
490 RENAL FAILURE 196 0.0015
491 GASTRIC ULCER 28 0.0015
492 RHEUMATOID ARTHRITIS 167 0.0015
493 HAEMOGLOBIN DECREASED 151 0.0015
494 NEUTROPHIL COUNT INCREASED 15 0.0015
495 ARTHRITIS BACTERIAL 6 0.0015
496 POST PROCEDURAL HAEMORRHAGE 17 0.0015
497 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 34 0.0015
498 CHOLESTASIS 28 0.0015
499 INTESTINAL ISCHAEMIA 8 0.0015
500 MUCOSAL INFLAMMATION 38 0.0014
501 PNEUMOTHORAX 23 0.0014
502 RASH VESICULAR 7 0.0014
503 ENCEPHALITIS 10 0.0014
504 LARGE INTESTINE PERFORATION 10 0.0014
505 URINARY RETENTION 48 0.0014
506 ARTHRITIS 113 0.0014
507 END STAGE RENAL DISEASE 26 0.0014
508 NEPHROPATHY TOXIC 16 0.0014
509 PHOTOPSIA 9 0.0014
510 HYPOXIA 50 0.0014
511 ABSCESS LIMB 6 0.0014
512 CARDIAC FAILURE CONGESTIVE 113 0.0014
513 THROMBOCYTOPENIA 157 0.0014
514 HYPOGLYCAEMIA 68 0.0014
515 THIRST 25 0.0014
516 HEPATIC STEATOSIS 26 0.0014
517 GINGIVAL BLEEDING 19 0.0014
518 CARDIOMEGALY 17 0.0014
519 COAGULOPATHY 23 0.0014
520 MOBILITY DECREASED 99 0.0014
521 TENDON RUPTURE 17 0.0014
522 MUSCULOSKELETAL STIFFNESS 120 0.0014
523 INTERNATIONAL NORMALISED RATIO INCREASED 39 0.0014
524 RED BLOOD CELL COUNT DECREASED 39 0.0014
525 MOUTH HAEMORRHAGE 10 0.0014
526 ERYTHEMA 280 0.0014
527 CACHEXIA 7 0.0014
528 HEPATIC FAILURE 41 0.0014
529 ACUTE RESPIRATORY DISTRESS SYNDROME 24 0.0014
530 SEPSIS 151 0.0014
531 RASH MACULO-PAPULAR 30 0.0013
532 VENTRICULAR EXTRASYSTOLES 14 0.0013
533 SHOCK 31 0.0013
534 MYOCLONUS 16 0.0013
535 TRANSFUSION 14 0.0013
536 ELECTROCARDIOGRAM QT PROLONGED 48 0.0013
537 METASTASES TO LYMPH NODES 9 0.0013
538 CARDIOGENIC SHOCK 19 0.0013
539 BODY TEMPERATURE DECREASED 13 0.0013
540 PERIPHERAL SWELLING 203 0.0013
541 CYTOPENIA 16 0.0013
542 DEHYDRATION 174 0.0013
543 VASCULITIS 15 0.0013
544 PYREXIA 442 0.0013
545 RENAL DISORDER 59 0.0013
546 VENTRICULAR FIBRILLATION 14 0.0013
547 RECALLED PRODUCT ADMINISTERED 12 0.0013
548 LIVER FUNCTION TEST INCREASED 27 0.0013
549 PERITONITIS 26 0.0013
550 WHITE BLOOD CELL COUNT INCREASED 48 0.0012
551 BLOOD TRIGLYCERIDES INCREASED 22 0.0012
552 ISCHAEMIC STROKE 22 0.0012
553 PNEUMONIA 393 0.0012
554 SARS-COV-2 TEST POSITIVE 16 0.0012
555 ABDOMINAL TENDERNESS 6 0.0012
556 METABOLIC DISORDER 7 0.0012
557 THERAPEUTIC RESPONSE DECREASED 73 0.0012
558 KETOACIDOSIS 9 0.0012
559 PERIPHERAL SENSORY NEUROPATHY 7 0.0012
560 ACUTE RESPIRATORY FAILURE 23 0.0012
561 FACE OEDEMA 20 0.0012
562 BLOOD BILIRUBIN INCREASED 32 0.0012
563 TROPONIN INCREASED 9 0.0012
564 RESPIRATORY FAILURE 86 0.0012
565 PNEUMONITIS 32 0.0012
566 HEAD INJURY 37 0.0012
567 ARTERIOSCLEROSIS 11 0.0012
568 SQUAMOUS CELL CARCINOMA 11 0.0012
569 CEREBRAL ISCHAEMIA 6 0.0012
570 MALNUTRITION 13 0.0012
571 GANGRENE 7 0.0012
572 RESPIRATORY DISTRESS 32 0.0012
573 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 9 0.0012
574 HIATUS HERNIA 15 0.0012
575 EJECTION FRACTION DECREASED 18 0.0012
576 NEUTROPENIA 155 0.0011
577 ATELECTASIS 11 0.0011
578 DEPRESSED LEVEL OF CONSCIOUSNESS 45 0.0011
579 PAPULE 8 0.0011
580 MYOCARDITIS 13 0.0011
581 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
582 PURPURA 10 0.0011
583 TRANSPLANT REJECTION 9 0.0011
584 HEPATIC ENZYME INCREASED 76 0.0011
585 DECUBITUS ULCER 9 0.0011
586 LYMPHADENOPATHY 39 0.0011
587 LIVER INJURY 27 0.0011
588 PULMONARY OEDEMA 49 0.0011
589 PROCTALGIA 7 0.0011
590 HYPERTENSION 229 0.0011
591 BACTERIAL INFECTION 20 0.0011
592 HYPOTENSION 214 0.0011
593 SENSORY DISTURBANCE 17 0.0011
594 GASTROINTESTINAL HAEMORRHAGE 88 0.0011
595 DERMATITIS 22 0.0010
596 SKIN DISORDER 35 0.0010
597 BLOOD ALKALINE PHOSPHATASE INCREASED 26 0.0010
598 JOINT EFFUSION 7 0.0010
599 CARDIOMYOPATHY 15 0.0010
600 FAECES DISCOLOURED 22 0.0010
601 HEPATIC CIRRHOSIS 19 0.0010
602 RENAL CYST 8 0.0010
603 GINGIVAL PAIN 8 0.0010
604 COLITIS 38 0.0010
605 HEPATITIS C 12 0.0010
606 NOCTURIA 12 0.0010
607 DIALYSIS 14 0.0010
608 SINUS TACHYCARDIA 14 0.0010
609 POLLAKIURIA 41 0.0010
610 RETINAL HAEMORRHAGE 7 0.0010
611 BLOOD THYROID STIMULATING HORMONE INCREASED 9 0.0010
612 ENCEPHALOPATHY 24 0.0010
613 MYOCARDIAL ISCHAEMIA 11 0.0010
614 POOR VENOUS ACCESS 10 0.0010
615 APPENDICITIS 9 0.0010
616 PRODUCT USE ISSUE 181 0.0010
617 INTERNAL HAEMORRHAGE 11 0.0010
618 SECOND PRIMARY MALIGNANCY 8 0.0010
619 SYNCOPE 96 0.0010
620 FOLLICULITIS 10 0.0010
621 DELIRIUM 33 0.0009
622 HAEMATEMESIS 24 0.0009
623 SUDDEN DEATH 10 0.0009
624 HEPATIC CYTOLYSIS 12 0.0009
625 CONSTIPATION 205 0.0009
626 RASH 409 0.0009
627 HYPERCHOLESTEROLAEMIA 9 0.0009
628 PRESCRIBED OVERDOSE 18 0.0009
629 COVID-19 163 0.0009
630 HERPES ZOSTER 53 0.0009
631 PLATELET COUNT INCREASED 12 0.0009
632 BLOOD GLUCOSE ABNORMAL 17 0.0009
633 TRANSIENT ISCHAEMIC ATTACK 31 0.0009
634 METASTASES TO LIVER 16 0.0009
635 HAEMOLYSIS 7 0.0009
636 LUNG INFILTRATION 8 0.0009
637 HYPERTHYROIDISM 13 0.0009
638 FULL BLOOD COUNT DECREASED 18 0.0009
639 JAUNDICE 24 0.0009
640 UNDERDOSE 65 0.0009
641 OXYGEN SATURATION DECREASED 50 0.0009
642 BLOOD ALBUMIN DECREASED 7 0.0009
643 URINARY TRACT INFECTION 150 0.0009
644 HELICOBACTER INFECTION 9 0.0009
645 DERMATITIS ALLERGIC 11 0.0009
646 GASTRITIS 23 0.0009
647 GASTRIC HAEMORRHAGE 10 0.0009
648 HYPERBILIRUBINAEMIA 9 0.0009
649 UROSEPSIS 8 0.0009
650 DIARRHOEA 559 0.0009
651 DIABETES MELLITUS 66 0.0009
652 NEOPLASM PROGRESSION 30 0.0009
653 CORONARY ARTERY DISEASE 26 0.0009
654 NEUROTOXICITY 15 0.0009
655 POLYURIA 7 0.0009
656 ANAPHYLACTIC SHOCK 22 0.0009
657 PHOTOSENSITIVITY REACTION 14 0.0008
658 DEEP VEIN THROMBOSIS 55 0.0008
659 FLUID RETENTION 43 0.0008
660 JOINT SWELLING 102 0.0008
661 INFECTION 122 0.0008
662 HAEMATOTOXICITY 8 0.0008
663 LYMPHOMA 13 0.0008
664 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 8 0.0008
665 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
666 SKIN LACERATION 9 0.0008
667 ASPIRATION 9 0.0008
668 ERECTILE DYSFUNCTION 21 0.0008
669 DYSURIA 30 0.0008
670 HEPATOMEGALY 8 0.0008
671 BLOOD MAGNESIUM DECREASED 7 0.0008
672 TRANSAMINASES INCREASED 18 0.0008
673 STOMATITIS 49 0.0008
674 ACUTE HEPATIC FAILURE 11 0.0008
675 INTESTINAL PERFORATION 9 0.0008
676 RESPIRATORY ARREST 22 0.0008
677 DIVERTICULITIS 22 0.0008
678 DIABETES MELLITUS INADEQUATE CONTROL 14 0.0008
679 MUSCLE ATROPHY 10 0.0008
680 CARDIO-RESPIRATORY ARREST 33 0.0008
681 TREATMENT NONCOMPLIANCE 43 0.0008
682 ABDOMINAL DISCOMFORT 131 0.0008
683 METASTASES TO LUNG 9 0.0008
684 CLOSTRIDIUM DIFFICILE INFECTION 17 0.0008
685 OROPHARYNGEAL DISCOMFORT 7 0.0008
686 CONDITION AGGRAVATED 235 0.0008
687 HYPERSENSITIVITY 143 0.0008
688 PARALYSIS 11 0.0008
689 HYPOKINESIA 11 0.0008
690 PRODUCTIVE COUGH 36 0.0008
691 OBESITY 12 0.0008
692 PAIN IN JAW 21 0.0007
693 FRACTURE 14 0.0007
694 BONE MARROW FAILURE 15 0.0007
695 IMMUNODEFICIENCY 11 0.0007
696 COLD SWEAT 13 0.0007
697 HAEMORRHAGE INTRACRANIAL 11 0.0007
698 SLEEP APNOEA SYNDROME 14 0.0007
699 RASH ERYTHEMATOUS 35 0.0007
700 CHOLELITHIASIS 24 0.0007
701 DYSPNOEA 413 0.0007
702 LEUKOCYTOSIS 13 0.0007
703 HAEMORRHOIDS 14 0.0007
704 PERICARDITIS 12 0.0007
705 LIMB DISCOMFORT 22 0.0007
706 BLINDNESS UNILATERAL 10 0.0007
707 HYPOPHAGIA 18 0.0007
708 URTICARIA 117 0.0007
709 FALL 232 0.0007
710 PRODUCT ADMINISTRATION ERROR 14 0.0007
711 TASTE DISORDER 14 0.0007
712 OSTEONECROSIS OF JAW 17 0.0007
713 FEMUR FRACTURE 21 0.0007
714 DISEASE PROGRESSION 80 0.0007
715 BLOOD PRESSURE INCREASED 103 0.0007
716 PETECHIAE 7 0.0007
717 POLYNEUROPATHY 8 0.0007
718 ANAL INCONTINENCE 6 0.0007
719 ORAL HERPES 13 0.0007
720 BLISTER 37 0.0007
721 OFF LABEL USE 576 0.0007
722 ABDOMINAL PAIN 153 0.0007
723 CORONARY ARTERY OCCLUSION 9 0.0007
724 DISORIENTATION 26 0.0007
725 LOSS OF CONSCIOUSNESS 84 0.0007
726 CONJUNCTIVITIS 12 0.0006
727 PHARYNGITIS 8 0.0006
728 FEEDING DISORDER 13 0.0006
729 BLOOD TEST ABNORMAL 9 0.0006
730 INSOMNIA 170 0.0006
731 NAUSEA 504 0.0006
732 BRONCHITIS 47 0.0006
733 BLOOD POTASSIUM DECREASED 19 0.0006
734 SKIN INFECTION 7 0.0006
735 GLAUCOMA 12 0.0006
736 NEUROPATHY PERIPHERAL 59 0.0006
737 LEUKOPENIA 31 0.0006
738 MALAISE 269 0.0006
739 MEDICATION ERROR 34 0.0006
740 NEPHROLITHIASIS 28 0.0006
741 SPINAL FRACTURE 12 0.0006
742 HEADACHE 375 0.0006
743 GLYCOSYLATED HAEMOGLOBIN INCREASED 15 0.0006
744 GASTRIC CANCER 15 0.0006
745 BLOOD IRON DECREASED 7 0.0006
746 MUSCULAR WEAKNESS 67 0.0006
747 PALPITATIONS 69 0.0006
748 ANGIOEDEMA 26 0.0006
749 ADVERSE EVENT 54 0.0006
750 MALIGNANT NEOPLASM PROGRESSION 60 0.0006
751 RIB FRACTURE 12 0.0006
752 BACK PAIN 134 0.0006
753 CHROMATURIA 13 0.0006
754 INCREASED APPETITE 11 0.0006
755 ABDOMINAL DISTENSION 60 0.0006
756 BRAIN FOG 9 0.0006
757 DRUG PRESCRIBING ERROR 11 0.0006
758 RENAL INJURY 17 0.0006
759 VIRAL INFECTION 19 0.0006
760 DISEASE RECURRENCE 27 0.0006
761 RENAL FAILURE ACUTE 24 0.0006
762 SEASONAL ALLERGY 8 0.0006
763 SCIATICA 9 0.0006
764 PEMPHIGUS 7 0.0006
765 CARDIAC ARREST 46 0.0006
766 EPILEPSY 17 0.0006
767 ARTHRALGIA 231 0.0006
768 METASTASES TO BONE 9 0.0005
769 HEPATITIS 14 0.0005
770 COUGH 153 0.0005
771 METASTASES TO CENTRAL NERVOUS SYSTEM 7 0.0005
772 SKIN HAEMORRHAGE 8 0.0005
773 FEELING COLD 15 0.0005
774 PLASMA CELL MYELOMA 21 0.0005
775 BLOOD CALCIUM DECREASED 6 0.0005
776 TACHYCARDIA 47 0.0005
777 SOPOR 7 0.0005
778 COMA 25 0.0005
779 OVERDOSE 113 0.0005
780 HIP ARTHROPLASTY 8 0.0005
781 MOUTH ULCERATION 11 0.0005
782 UPPER RESPIRATORY TRACT INFECTION 24 0.0005
783 LUNG INFECTION 8 0.0005
784 CYANOSIS 8 0.0005
785 MYALGIA 86 0.0005
786 TYPE 2 DIABETES MELLITUS 17 0.0005
787 DYSARTHRIA 19 0.0005
788 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
789 ABSCESS 8 0.0005
790 RESPIRATORY DISORDER 15 0.0005
791 ECZEMA 26 0.0005
792 OSTEOARTHRITIS 21 0.0005
793 PRESYNCOPE 12 0.0005
794 CATARACT 29 0.0005
795 STAPHYLOCOCCAL INFECTION 16 0.0005
796 PULMONARY EMBOLISM 46 0.0005
797 FLUID OVERLOAD 7 0.0005
798 CHEST DISCOMFORT 49 0.0005
799 INTESTINAL OBSTRUCTION 18 0.0005
800 BLOOD SODIUM DECREASED 9 0.0005
801 MUSCULOSKELETAL PAIN 25 0.0005
802 HALLUCINATION, VISUAL 10 0.0005
803 VOMITING 222 0.0005
804 PULMONARY MASS 7 0.0005
805 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 84 0.0005
806 ACCIDENTAL OVERDOSE 17 0.0005
807 APHASIA 14 0.0005
808 DIPLOPIA 12 0.0005
809 DYSPHONIA 27 0.0005
810 CHILLS 54 0.0005
811 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 24 0.0005
812 DIABETIC KETOACIDOSIS 11 0.0005
813 ASTHENIA 169 0.0004
814 LUNG DISORDER 22 0.0004
815 GAIT INABILITY 15 0.0004
816 PAIN OF SKIN 12 0.0004
817 TOXICITY TO VARIOUS AGENTS 75 0.0004
818 HEART RATE INCREASED 44 0.0004
819 FLATULENCE 25 0.0004
820 HAEMORRHAGE 46 0.0004
821 PAIN 269 0.0004
822 PRURITUS 168 0.0004
823 MOVEMENT DISORDER 14 0.0004
824 THROMBOSIS 35 0.0004
825 WEIGHT INCREASED 97 0.0004
826 CHEST PAIN 80 0.0004
827 LACRIMATION INCREASED 13 0.0004
828 WOUND 12 0.0004
829 ALOPECIA 83 0.0004
830 INTENTIONAL DOSE OMISSION 12 0.0004
831 FUNGAL INFECTION 14 0.0004
832 FATIGUE 327 0.0004
833 PANCREATIC CARCINOMA 12 0.0004
834 SWELLING FACE 27 0.0004
835 LUNG NEOPLASM MALIGNANT 17 0.0004
836 APATHY 6 0.0004
837 RESTLESSNESS 15 0.0004
838 CYSTITIS 13 0.0004
839 NASOPHARYNGITIS 75 0.0004
840 ORAL PAIN 9 0.0004
841 GASTROINTESTINAL DISORDER 36 0.0004
842 HYPOAESTHESIA 60 0.0004
843 DYSPHAGIA 38 0.0004
844 HEART RATE DECREASED 14 0.0004
845 WEIGHT DECREASED 111 0.0004
846 CONTUSION 38 0.0004
847 INFLUENZA 44 0.0004
848 SKIN DISCOLOURATION 18 0.0004
849 DIZZINESS 195 0.0004
850 LIP SWELLING 13 0.0004
851 GASTROENTERITIS VIRAL 7 0.0004
852 GASTROOESOPHAGEAL REFLUX DISEASE 31 0.0004
853 CONFUSIONAL STATE 62 0.0004
854 KNEE ARTHROPLASTY 8 0.0004
855 PRODUCT USE IN UNAPPROVED INDICATION 94 0.0004
856 EATING DISORDER 8 0.0004
857 SWELLING 35 0.0004
858 RECTAL HAEMORRHAGE 16 0.0004
859 POOR QUALITY SLEEP 8 0.0004
860 RHINORRHOEA 24 0.0004
861 PRURITUS GENERALISED 8 0.0004
862 PAIN IN EXTREMITY 109 0.0004
863 PRODUCT PRESCRIBING ISSUE 8 0.0004
864 MUSCLE SPASMS 67 0.0004
865 SEROTONIN SYNDROME 7 0.0004
866 ASTHMA 41 0.0004
867 PANCREATITIS 19 0.0004
868 HEPATOTOXICITY 8 0.0004
869 ROAD TRAFFIC ACCIDENT 15 0.0004
870 NECK PAIN 20 0.0004
871 RASH PAPULAR 8 0.0004
872 CANDIDA INFECTION 6 0.0004
873 HEART RATE IRREGULAR 8 0.0004
874 RESPIRATORY TRACT INFECTION 9 0.0003
875 HALLUCINATION 26 0.0003
876 ANAPHYLACTIC REACTION 19 0.0003
877 LIVER FUNCTION TEST ABNORMAL 10 0.0003
878 BODY TEMPERATURE INCREASED 7 0.0003
879 EYE PAIN 19 0.0003
880 ABDOMINAL PAIN UPPER 69 0.0003
881 OSTEONECROSIS 11 0.0003
882 MYOCARDIAL INFARCTION 58 0.0003
883 HOT FLUSH 25 0.0003
884 LIMB INJURY 9 0.0003
885 DEATH 285 0.0003
886 TINNITUS 15 0.0003
887 SKIN CANCER 7 0.0003
888 DEMENTIA 9 0.0003
889 MENTAL DISORDER 14 0.0003
890 AGEUSIA 8 0.0003
891 INTENTIONAL PRODUCT USE ISSUE 28 0.0003
892 TOOTH DISORDER 7 0.0003
893 VISUAL IMPAIRMENT 39 0.0003
894 HYPERSOMNIA 9 0.0003
895 OROPHARYNGEAL PAIN 29 0.0003
896 NIGHT SWEATS 10 0.0003
897 DYSSTASIA 9 0.0003
898 THERAPY INTERRUPTED 22 0.0003
899 NASAL CONGESTION 18 0.0003
900 DYSPEPSIA 30 0.0003
901 GAIT DISTURBANCE 58 0.0003
902 DRUG INEFFECTIVE 397 0.0003
903 BLOOD PRESSURE FLUCTUATION 7 0.0003
904 HEPATIC CANCER 7 0.0003
905 LOCALISED INFECTION 7 0.0003
906 BALANCE DISORDER 25 0.0003
907 WHEEZING 17 0.0003
908 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
909 SKIN EXFOLIATION 24 0.0003
910 SLEEP DISORDER 20 0.0003
911 VERTIGO 17 0.0003
912 CARDIOVASCULAR DISORDER 7 0.0003
913 IMPAIRED HEALING 9 0.0003
914 THERAPY CESSATION 14 0.0003
915 DRUG RESISTANCE 7 0.0003
916 CEREBROVASCULAR ACCIDENT 46 0.0003
917 UNRESPONSIVE TO STIMULI 7 0.0003
918 VISUAL ACUITY REDUCED 9 0.0003
919 DRY SKIN 36 0.0003
920 SOMNOLENCE 54 0.0003
921 DEAFNESS 7 0.0003
922 SINUSITIS 27 0.0003
923 LETHARGY 15 0.0003
924 GYNAECOMASTIA 8 0.0003
925 SKIN LESION 7 0.0003
926 PROCEDURAL PAIN 7 0.0003
927 VISION BLURRED 34 0.0002
928 FEELING HOT 15 0.0002
929 EYE DISORDER 8 0.0002
930 SEIZURE 28 0.0002
931 EYE SWELLING 9 0.0002
932 BONE PAIN 14 0.0002
933 LABORATORY TEST ABNORMAL 7 0.0002
934 COGNITIVE DISORDER 11 0.0002
935 BLOOD GLUCOSE INCREASED 44 0.0002
936 DISCOMFORT 14 0.0002
937 SWOLLEN TONGUE 7 0.0002
938 DYSKINESIA 9 0.0002
939 SKIN IRRITATION 10 0.0002
940 HIP FRACTURE 7 0.0002
941 BLOOD CHOLESTEROL INCREASED 10 0.0002
942 DRY MOUTH 17 0.0002
943 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 42 0.0002
944 TREMOR 34 0.0002
945 CARDIAC DISORDER 19 0.0002
946 HOSPITALISATION 31 0.0002
947 DRY EYE 10 0.0002
948 PRODUCT DOSE OMISSION ISSUE 58 0.0002
949 BLINDNESS 8 0.0002
950 OSTEOPOROSIS 8 0.0002
951 OCULAR HYPERAEMIA 9 0.0002
952 HYPOACUSIS 8 0.0002
953 AMNESIA 12 0.0002
954 PARAESTHESIA 29 0.0002
955 INTENTIONAL PRODUCT MISUSE 16 0.0002
956 NEOPLASM MALIGNANT 12 0.0002
957 ILLNESS 18 0.0002
958 EYE IRRITATION 10 0.0002
959 SPEECH DISORDER 9 0.0002
960 HYPERHIDROSIS 22 0.0002
961 BLOOD GLUCOSE DECREASED 8 0.0002
962 COLITIS ULCERATIVE 7 0.0002
963 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
964 FEELING ABNORMAL 37 0.0002
965 MEMORY IMPAIRMENT 21 0.0002
966 DEPRESSED MOOD 8 0.0002
967 DEPRESSION 34 0.0001
968 ILL-DEFINED DISORDER 9 0.0001
969 DYSGEUSIA 11 0.0001
970 RENAL CANCER 7 0.0001
971 INJURY 10 0.0001
972 ANXIETY 40 0.0001
973 PRODUCT SUBSTITUTION ISSUE 8 0.0001
974 PSORIASIS 18 0.0001
975 SURGERY 8 0.0001
976 BLADDER CANCER 8 0.0001
977 FLUSHING 13 0.0001
978 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
979 INJECTION SITE REACTION 8 0.0001
980 MIGRAINE 11 0.0001
981 PROSTATE CANCER 9 0.0001
982 INTENTIONAL OVERDOSE 7 0.0001
983 PRODUCT DOSE OMISSION 7 0.0001
984 INCORRECT DOSE ADMINISTERED 24 0.0001
985 BURNING SENSATION 7 0.0001
986 NO ADVERSE EVENT 18 0.0001
987 AGITATION 7 0.0001
988 EMOTIONAL DISTRESS 11 0.0001
989 DEVICE ISSUE 8 0.0001
990 INFLUENZA LIKE ILLNESS 7 0.0001
991 INJECTION SITE ERYTHEMA 10 0.0001
992 INJECTION SITE PAIN 21 0.0001
993 BREAST CANCER 6 0.0001